These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38328494)

  • 41. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis.
    Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL
    Chest; 2024 May; 165(5):1058-1069. PubMed ID: 38086472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study.
    Watanabe F; Kaburaki S; Furuuchi K; Uesugi F; Fujiwara K; Tanaka Y; Yoshiyama T; Shiraishi Y; Kurashima A; Ohta K; Hanada K; Morimoto K
    Infection; 2022 Aug; 50(4):879-887. PubMed ID: 35106717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
    Lin S; Hua W; Wang S; Zhang Y; Chen X; Liu H; Shao L; Chen J; Zhang W
    BMC Microbiol; 2022 Jul; 22(1):175. PubMed ID: 35804298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of clofazimine-modified cyclodextrin against Mycobacterium avium complex in human macrophages.
    Salem II; Steffan G; Düzgünes N
    Int J Pharm; 2003 Jul; 260(1):105-14. PubMed ID: 12818815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G; Ducrot R; Bourdin A; Rastogi N
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study.
    Zaheen A; Hirama T; Mehrabi M; Brode SK; Marras TK
    Respir Med; 2020 Jun; 167():105967. PubMed ID: 32421543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
    Jeong BH; Jeon K; Park HY; Moon SM; Kim SY; Lee SY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6076-83. PubMed ID: 27480854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS.
    Abrams DI; Mitchell TF; Child CC; Shiboski SC; Brosgart CL; Mass MM
    J Infect Dis; 1993 Jun; 167(6):1459-63. PubMed ID: 8501340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease.
    Kim EY; Chi SY; Oh IJ; Kim KS; Kim YI; Lim SC; Kim YC; Kwon YS
    Korean J Intern Med; 2011 Mar; 26(1):54-9. PubMed ID: 21437163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clofazimine as a substitute for rifampicin improves efficacy of
    Salillas S; Raaijmakers J; Aarnoutse RE; Svensson EM; Asouit K; van den Hombergh E; Te Brake L; Stemkens R; Wertheim HFL; Hoefsloot W; van Ingen J
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0115723. PubMed ID: 38259101
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
    Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL
    Clin Infect Dis; 2023 Feb; 76(3):e1408-e1415. PubMed ID: 35607719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solitary pulmonary nodules caused by Mycobacterium avium complex.
    Marukawa M; Taniguchi A; Kimura G; Kunichika N; Kuyama S; Maeda Y; Kiura K; Miyahara N;
    Respir Investig; 2019 Nov; 57(6):566-573. PubMed ID: 31402330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality.
    Im Y; Hwang NY; Kim K; Kim H; Kwon OJ; Jhun BW
    Chest; 2022 May; 161(5):1192-1200. PubMed ID: 34793759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of nontuberculous mycobacterial infections in pediatric patients.
    Levin RH; Bolinger AM
    Clin Pharm; 1988 Jul; 7(7):545-51. PubMed ID: 2843317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease.
    Ando T; Kage H; Matsumoto Y; Zokumasu K; Nagase T
    Respir Investig; 2021 Nov; 59(6):777-782. PubMed ID: 34389250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease.
    Ito M; Furuuchi K; Fujiwara K; Watanabe F; Kodama T; Uesugi F; Tanaka Y; Yoshiyama T; Kurashima A; Ohta K; Morimoto K
    Respir Med; 2023; 219():107417. PubMed ID: 37775085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.
    Sullam PM; Gordin FM; Wynne BA
    Clin Infect Dis; 1994 Jul; 19(1):84-6. PubMed ID: 7948562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rifabutin in the treatment of Mycobacterium avium complex infection: experience in Europe.
    Dautzenberg B
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S33-6. PubMed ID: 8785254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.